Ahmedabad-based pharma major Zydus Cadila has received the final approval from the US drug regulator to market Telmisartan tablets. The company... ...http://www.business-standard.com/article/companies/zydus-cadila-gets-usfda-nod-for-anti-hypertension-drug-114082900729_1.html
Even as Indian drugmakers are looking at biosimilars as the next big thing, it may take a few years before it kicks off as a mainstream revenue... ...http://www.mydigitalfc.com/news/no-biosimilars-rollout-next-five-years-687
Even as countries such as China, Japan and Vietnam are investing heavily in Myanmar, capital inflows from India into that country lag. Now, the... ...http://www.business-standard.com/article/economy-policy/myanmar-unhappy-with-india-s-window-shopping-attitude-114082700022_1.html
The latest government order to control prices of certain drugs in the cardiovascular and anti-diabetic segments may only cause some near-term... ...http://www.thehindu.com/business/Industry/a-feel-good-order-for-consumers-but-a-pain-for-the-pharmaceutical-industry/article6345285.ece
AHMEDABAD: Ahmedabad-based drug maker Marck Biosciences has been issued a warning letter by US drug authority after an inspection last year found... ...http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-issues-warning-to-indian-drug-maker-marck-biosciences/articleshow/40668333.cms
Meher Pharma International provides...
The company was formed way back in...